Development and evaluation of lorazepam microemulsions for parenteral delivery

AAPS PharmSciTech

Volumn 9, Issue 3, 2008, Pages 966-971

  Kale, Amit A ^a   Patravale, Vandana B ^a  

^a INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

Capmul MCM; Lorazepam; Parenteral microemulsion; Poor aqueous solubility

Indexed keywords

AMINO ACID; INFUSION FLUID; LORAZEPAM; OIL; POLYSORBATE 80;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CRYOPRESERVATION; DRUG DELIVERY SYSTEM; DRUG INCOMPATIBILITY; DRUG SCREENING; DRUG SOLUBILITY; DRUG STABILITY; DRUG SYNTHESIS; ERYTHROCYTE; HEMOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROEMULSION; PARENTERAL DRUG ADMINISTRATION; PHYSICAL CHEMISTRY;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; DRUG EVALUATION, PRECLINICAL; DRUG STABILITY; EMULSIONS; HEMOLYSIS; HUMANS; INFUSIONS, PARENTERAL; LETHAL DOSE 50; LORAZEPAM; MICE; SOLUBILITY;

EID: 57149147742     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-008-9131-z     Document Type: Article

References (15)

1. C. Holvoet, Y. V. Heyden, and J. Plaizier-Vercammen. Inclusion complexation of lorazepam with different cyclodextrins suitable for parenteral use. Drug Dev. Ind. Pharm. 31: 567-575 (2005).
2. R. G. Strickley. Solubilizing excipients in oral and injectable formulations. Pharm. Res. 21: 201-230 (2004).
3. A. A. Date, and M. S. Nagarsenker. Parenteral microemulsions: An overview. Int. J. Pharm. 355: 19-30 (2008).
4. M. Yalin, F. Öner, L. Öner, and A. A. Hincal. Preparation and properties of a stable intravenous lorazepam emulsion. J. Clin. Pharm. Ther. 22: 39-44 (1997).
5. J. Medina, A. Salvado, and A. Pozo. Use of ultrasound to prepare lipid emulsions of lorazepam for intravenous injection. Int. J. Pharm. 216: 1-8 (2001).
6. S. N. Bennett, M. M. McNeil, L. A. Bland, M. J. Arduino, M. E. Villarino, and D. M. Perrotta. Postoperative infections traced to contamination of an intravenous anesthetic, propofol. N. Engl. J. Med. 333: 147-154 (1995).
7. S. Tenjarla. Microemulsions: An overview and pharmaceutical applications. Crit. Rev. Ther. Drug Carr. Syst. 16: 461-521 (1999).
8. I. S. I. Al-Adham, E. Khalil, N. D. Al-Hmoud, M. Kierans, and P. J. Collier. Microemulsions are membrane-active, antimicrobial, self-preserving systems. J. Appl. Microbiol. 89: 32-39 (2000).
9. C. V. Corswant, S. Engstrom, and O. Söderman. Microemulsions based on soybean phosphotidylcholine and triglycerides. Phase behavior and microstructure. Langmuir 13: 5061-5070 (1997).
10. M. Jumma, P. Kleinebudde, and B. Muller. Physicochemical properties and hemolytic effect of different lipid emulsion formulations using a mixture of emulsifiers. Pharm. Acta Helv. 73: 293-301 (1999).
11. W. Warisnoicharoen, A. B. Lansley, and M. J. Lawrence. Nonionic oil-in-water microemulsions: The effect of oil type on phase behavior. Int. J. Pharm. 198: 7-27 (2000).
12. A. O. Nornoo, D. W. Osborne, and D. S. L. Chow. Cremophor-free intravenous microemulsions for paclitaxel I: Formulation, cytotoxicity and hemolysis. Int. J. Pharm. 349: 108-116 (2008).
13. P. Li, A. Ghosh, R. F. Wagner, S. Krill, Y. M. Joshi, and A. T. M. Serajuddin. Effect of combined use of nonionic surfactant on formation of oil-in-water microemulsions. Int. J. Pharm. 288: 27-34 (2005).
14. D. L. Nelson, and M. M. Cox (eds.), Lehninger Principles of Biochemistry. Worth, New York, 2000, pp 426-436.
15. F. Xun, L. Junling, M. Ying, Z. Li, W. Debao, and H. Zhengshui. Amino acid extraction with AOT reverse micelle. Colloids Surf. A 179: 1-10 (2001).